EquitAI LogoEquitAI
$220.83
-1.64%
BIIB

BIIB

Biogen Inc.

Healthcare
Loading Chart...
FIT ANALYSIS
Required for personalization
STOCK DNA
Valuation
5/10
Quality
9/10
Growth
6/10
Strength
6/10
Dividend
1/10
Price Trend
Upwards
Momentum
Stretched
Balance Sheet
Healthy
Earnings
Growth
Dividend Yield
0.00%
Market Cap
$32.63B
TALK TO YOUR STOCK
EQUITAI ASSISTANT

Biogen is a global biotechnology company that discovers, develops, and delivers therapies for complex neurological and neurodegenerative diseases. Its primary product lineup focuses on treating conditions like multiple sclerosis, spinal muscular atrophy, and Alzheimer's disease. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?

AI can make mistakes. Verify important information.
Talk to Your Stockopen live chat
Pro EquitAI Research
Retrieving premium status...